Courtney Beers
Direktor/Vorstandsmitglied bei SANGAMO THERAPEUTICS, INC.
Vermögen: 13 099 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Courtney Beers
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA.
12
| Holding Company | Biotechnology | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Courtney Beers
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Trishula Therapeutics, Inc.
 Trishula Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trishula Therapeutics, Inc. is a company solely dedicated to developing TTX-030, a first-in-class anti-CD39 antibody aimed at improving outcomes for people with cancer. Trishula Therapeutics is based in South San Francisco, CA. The company's leadership, board of directors, scientific advisory board, investors, and partners are all committed to this goal. Anil Singhal has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal Private Equity Investor Private Equity Investor | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| ACCELERON PHARMA INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Doctorate Degree | |
| RELYPSA INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Maryland | College/University | Graduate Degree | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Parker Institute For Cancer Immunotherapy
 The Parker Institute For Cancer Immunotherapy Miscellaneous Commercial ServicesCommercial Services The Parker Institute for Cancer Immunotherapy is a research organization that aims to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases. The Parker Institute for Cancer Immunotherapy is based in San Francisco, CA. The private company conducts clinical trials to tackle the toughest cancers and answer the hardest questions in immunotherapy. The institute coordinates cancer research efforts between the best scientists, clinicians, and partners in the industry. The company has legal experts who help their researchers navigate the intellectual property process and turn their cancer immunotherapy discoveries into treatments. It was founded by Sean N. Parker, Adam Kolom, Michael Polansky. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Operating Officer | |
The Phi Beta Kappa Society
 The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services The Phi Beta Kappa Society operates as an organization for liberal arts and science education. The non-profit company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member | |
| Uniformed Services University of the Health Sciences | College/University | Corporate Officer/Principal | |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services University of Miami (Florida) is a private research university with students from around the world that is focused on teaching and learning, the discovery of new knowledge, and service to the South Florida region and beyond. The university was founded in 1925 and it is headquartered in Coral Gables, FL. | College/University | Undergraduate Degree | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. Drugstore ChainsRetail Trade Amphivena Therapeutics, Inc. provides drug discovery services. It develops tetravalent, T-cell redirecting bispecific antibodies for the treatment of hematologic malignancies. The firm’s’ lead drug candidate is AMV-564, a CD33/CD3-targeting treatment for acute myeloid leukemia (AML), which Amphivena is currently preparing to advance into clinical development. The company was founded by Jeanmarie Guenot in December 2012 and is headquartered in San Francisco, CA. | Drugstore Chains | Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Precision Biologics, Inc.
 Precision Biologics, Inc. Drugstore ChainsRetail Trade Precision Biologics, Inc. develops therapeutic and diagnostic products for the early detection and treatment of cancer. Its antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. The company was founded in February 2012 and is headquartered in Dallas, TX. | Drugstore Chains | Director/Board Member | |
| ITEOS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of California | College/University | Undergraduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree | |
| London Business School | College/University | Masters Business Admin | |
Auris Medical AG
 Auris Medical AG Medical SpecialtiesHealth Technology Auris Medical AG manufactures electronic devices for ear disorders. It develops novel pharmaceutical therapies to protect hearing and to silence tinnitus. The company was founded by Thomas Meyer in April 2003 and is headquartered in Basel, Switzerland. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| University of Genoa | College/University | Doctorate Degree | |
Ambagon Therapeutics, Inc.
 Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer | |
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| Annamalai University | College/University | Doctorate Degree | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | General Counsel | |
| University of California, Davis | College/University | Undergraduate Degree | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Chief Executive Officer | |
| ANTARES PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Curtin University of Technology | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 3 |
| Kanada | 2 |
| Frankreich | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 17 |
| Commercial Services | 4 |
| Finance | 3 |
| Retail Trade | 3 |
Operativ
| Director/Board Member | 156 |
| Corporate Officer/Principal | 78 |
| Independent Dir/Board Member | 52 |
| Chief Tech/Sci/R&D Officer | 39 |
| Undergraduate Degree | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Nina Kjellson | 49 |
| Kurt von Emster | 34 |
| Karen Smith | 29 |
| Dan Spiegelman | 24 |
| Robert Carey | 23 |
| H. Parker | 22 |
| William Grossman | 13 |
| Pankaj Bhargava | 13 |
| Peg Horn | 12 |
| Joyson Karakunnel | 12 |
| Lisa Rojkjaer | 12 |
| Kenneth Hillan | 10 |
| James Meyers | 9 |
| R. Ramelmeier | 8 |
| Bettina Cockroft | 8 |
- Börse
- Insiders
- Courtney Beers
- Unternehmensverbindungen
